Caroline Robert, M.D., Ph.D. is the Head of the Dermatology Service at Gustave Roussy Cancer Campus and co-director of the Melanoma Research Unit at INSERM 981 Paris-Sud University. She trained at the Paris V University, France and completed a research fellowship at Harvard, Brigham & Women’s hospital in Cancer Immunology and Immunotherapy. She is full Professor of Dermatology and responsible for teaching Dermatology and Dermato-Oncology in Paris-Saclay University Medicine School. Her main interests are clinical and translational Research on Melanoma involving immunotherapy and targeted therapy. She is national and international coordinator of many clinical trials of targeted therapy and immunotherapy for melanoma patients, from phase I to III. Her research work focuses on the involvement of the control of mRNA translation in resistance to immunotherapy and targeted therapies for melanoma. The objectives are the identification of new predictive biomarkers as well as the development of new therapies to delay therapeutic resistance. She has authored more than 350 articles in peer-reviewed scientific journals, including a number of publications on new treatments for metastatic melanoma. She is past-president the Melanoma group of the European Organization for the Research and Treatment of Cancer (EORTC) and is board member for the European Association of Onco-Dermatology (EADO), the European Association of Dermato-Venereology (EADV) the French society of Dermatology and Venereology (SFD), the American Society of Oncology (ASCO) and the American Association of Clinical Research (AACR). She is a member of the European Society for Medical Oncology (ESMO) Leadership Generation Task Force.

She has received several awards and prizes including the French Legion d’Honneur in 2014, the INSERM Research Award and the Bettencourt Schueller Foudation Reasearch Award in 2015, the San Salvatore Foundation, Lugano Award in 2016, the Roy-Vaucouloux Award from the French Cancer League   the Rose Lamarca Award from the French Academy of Medicine    as well as the Memorial Holst Lecture Award in 2017, the  Translational Research Leopold Griffuel Award from the Association pour la Recherche sur le Cancer  and the Estela Medrano Award for the Society for Melanoma Research in 2018, ESMO Women for Oncology Award and Rosen Award from the Fondation pour la Recherche Médicale in 2020. She was elected as a corresponding member of the French National Academy of Medicine in 2019.